CAC Software vs Imbio RV/LV Software
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if your primary objective is to automatically quantify coronary artery calcification from non-contrast chest CT scans. This tool is ideal for radiologists and cardiologists focused on assessing a patient's risk for coronary artery disease by providing Agatston scores, arterial age, and detailed 3D visualizations.
View CAC Software →Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if you need an AI-powered solution to automatically measure right and left ventricular diameters from CTPA scans. This tool is best suited for aiding in risk stratification for pulmonary conditions, such as pulmonary embolism, by quickly calculating and reporting the crucial RV/LV ratio.
View Imbio RV/LV Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | Imbio RV/LV Software |
|---|---|---|
| Deployment | Cloud-based (SaaS), integrates with PACS | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools emphasize fully automated workflows and seamless integration into existing clinical environments. Tool A integrates into existing DICOM viewing workflows and runs automatically with no user intervention. Similarly, Tool B offers a fully automated workflow with no user intervention required after scan completion and integrates with standard reading environments (PACS). Both are designed for minimal user input and ease of use within a radiological workflow.
Clinical Value
TieBoth tools provide critical quantitative data for risk stratification in distinct, yet equally important, clinical areas. Tool A quantifies coronary artery calcification, a key biomarker for cardiovascular disease risk. Tool B measures RV/LV ratios for risk stratification in pulmonary conditions like pulmonary embolism, a vital metric for patient management. Each offers high clinical utility by providing objective measurements that aid in significant medical decision-making.
Pricing & Value
Imbio RV/LV SoftwareTool B offers more transparency regarding its pricing model, stating it is subscription-based and determined by the number of analyses or installations. In contrast, Tool A only indicates 'contact for pricing.' This greater clarity from Tool B allows potential customers to better understand the cost structure upfront.
Enterprise Readiness
Imbio RV/LV SoftwareWhile both tools are FDA cleared, HIPAA compliant, and offer flexible deployment options (cloud, on-premise, partner platforms), Tool B provides slightly more detail. It explicitly mentions 'third-party hipaa compliant certified by compliancy group' and lists a broader range of specific partner platforms, suggesting a more extensively validated and integrated enterprise solution.
Innovation
TieBoth tools demonstrate innovation by leveraging advanced AI and deep learning algorithms for automated medical image analysis. Tool A uses deep learning for coronary artery calcification quantification and 3D visualizations, while Tool B employs an AI algorithm for automated ventricular measurement. Neither presents a unique technological breakthrough that significantly surpasses the other in terms of innovative approach within the AI-powered medical imaging space.
Support & Docs
TieAs both tools are products of Imbio, they benefit from the same company-wide customer support and documentation infrastructure. Imbio offers 24/7/365 support via email and website tickets, phone support during business hours, and provides user manuals and FAQs for its products. There is no indication that one product receives superior support or documentation over the other.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | Imbio RV/LV Software |
|---|---|---|
| Name | CAC Software | Imbio RV/LV Software |
| Company | Imbio | Imbio |
| Description | Automated image post-processing algorithms to determine location and calculate amount of calcification within coronary arteries from non-contrast chest CT. | AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. |
| Key Features | Automated image post-processing for coronary artery calcification; Quantification of calcification within coronary arteries; Outputs Agatston score, arterial age, calcified lesion mass and volume; Provides 3D visualizations and annotated images; Non-invasive analysis from non-contrast chest CT scans; Integrates into existing DICOM viewing workflow; Supports risk assessment for coronary artery disease; Deep-learning based analysis | Automated measurement of right and left ventricular diameters; Calculation and reporting of RV/LV ratio; Artificial intelligence algorithm for ventricle identification and measurement; Provides annotated images showing ventricular measurements; Generates summary PDF reports; Fully automated workflow, no user intervention required after scan completion; DICOM compliant input and output; Integration with standard reading environments (PACS) |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and Imbio RV/LV Software.